Crossmark

Efficacy and safety of isavuconazole versus voriconazole for the treatment of invasive fungal infections: a meta-analysis with trial sequential analysis

Crossref DOI link: https://doi.org/10.1186/s12879-025-10627-w

Published Online: 2025-02-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Weng, Jianzhen

Du, Xiaoman

Fang, Baomin

Li, Yanming

Huang, Lixue

Ju, Yang
License Information

Text and Data Mining valid from 2025-02-18

Version of Record valid from 2025-02-18
More Information

Article History

Received: 23 August 2024

Accepted: 11 February 2025

First Online: 18 February 2025

Declarations

:

: Not applicable.

: Not applicable. This study did not involve human participants.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below